Sarepta Therapeutics to Present at the Morgan Stanley 17th Annual Global Healthcare Conference
September 03 2019 - 4:30PM
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision
genetic medicine for rare diseases, today announced that senior
management will present at the Morgan Stanley 17th Annual Global
Healthcare Conference on Monday, September 9, 2019 at 11:05 a.m.
ET. The fireside chat will be held at the Grand Hyatt New York in
New York City, NY.
The presentation will be webcast live under the
investor relations section of Sarepta’s website at
www.sarepta.com and will be archived there following the
presentation for 90 days. Please connect to Sarepta's website
several minutes prior to the start of the broadcast to ensure
adequate time for any software download that may be necessary.
About Sarepta
TherapeuticsSarepta is at the forefront of precision
genetic medicine, having built an impressive and competitive
position in Duchenne muscular dystrophy (DMD) and more recently in
gene therapies for 6 Limb-girdle muscular dystrophy diseases
(LGMD), Charcot-Marie-Tooth (CMT), MPS IIIA, Pompe and other
CNS-related disorders, totaling over 20 therapies in various stages
of development. The Company’s programs and research focus span
several therapeutic modalities, including RNA, gene therapy and
gene editing. Sarepta is fueled by an audacious but important
mission: to profoundly improve and extend the lives of patients
with rare genetic-based diseases. For more information, please
visit www.sarepta.com.
Internet Posting of
Information
We routinely post information that may be
important to investors in the 'For Investors' section of our
website at www.sarepta.com. We encourage investors and
potential investors to consult our website regularly for important
information about us.
Source: Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc.Investors: Ian
Estepan, 617-274-4052 iestepan@sarepta.com
Media:Tracy Sorrentino,
617-301-8566tsorrentino@sarepta.com
Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From Apr 2023 to Apr 2024